Conmed Corporation
—- Market cap
- —
- Debt
- +$834.23M
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: CNMD stock price vs ZS: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ZS's multiple
Needs ZS P/E.
Implied fair value · at CNMD's multiple
Needs Annual EPS is negative, CNMD P/E.
Metric by metric
Where each company leads, and how wide the gap is.
Price unavailable
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: CNMD FY 2025 (ended Dec 31, 2025) · ZS FY 2026 (ended Jul 31, 2026). Fiscal years are not aligned.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
CONMED CORPORATION · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Zscaler Inc · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.81x
0.73x
Net debt / EBITDA
Leverage against operating earnings
—
8.93x
Cash and equivalents
Liquid reserves on the balance sheet
—
$928.35M
Total debt
Interest-bearing obligations outstanding
$834.23M
$1.90B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
STRYKER CORP
CNMD vs SYK
ZIMMER BIOMET HOLDINGS, INC.
CNMD vs ZBH
INTEGRA LIFESCIENCES HOLDINGS CORP
CNMD vs IART
BAXTER INTERNATIONAL INC
CNMD vs BAX
Palo Alto Networks Inc
CNMD vs PANW
CrowdStrike Holdings, Inc.
CNMD vs CRWD
Okta, Inc.
CNMD vs OKTA
Cloudflare, Inc.
CNMD vs NET
Fortinet, Inc.
CNMD vs FTNT
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.